Savene (dexrazoxane)
- Region
- 🇪🇺 EU
- Active substance
- dexrazoxane
- Company
- CNX Therapeutics Ireland Limited
- Status
- Authorised
- Therapeutic area
- Extravasation of Diagnostic and Therapeutic Materials
- EU approval
- Thu 27 Jul 2006
- Application
- EMEA/H/C/000682
- ATC
- V03AF02
- Official record
- www.ema.europa.eu
Indication
Savene is indicated for the treatment of anthracycline extravasation.
Regulatory milestones
Thu 23 Apr 2026🇪🇺 DHPC safety letter
Savene (dexrazoxane): DHPC sent to healthcare professionals
Quality defect; Extravasation of Diagnostic and Therapeutic Materials · source
Follow Savene
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.